Scalzulli E - Search Results

1

Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature.

Iori AP, Ferretti A, Gentile G, Gabrielli S, Perrone S, Barberi W, Torelli GF, Natalino F, Scalzulli E, Totino V, Foà R, Cancrini G, Girmenia C. Iori AP, et al. Among authors: scalzulli e. Transpl Infect Dis. 2014 Aug;16(4):625-30. doi: 10.1111/tid.12239. Epub 2014 Jun 3. Transpl Infect Dis. 2014. PMID: 24890466 Review.

2

The limit for chronic myeloid leukemia relapse after allogeneic hematopoietic stem cell transplant moves ever forward: when can you safely talk about healing?

Iori AP, Breccia M, Girmenia C, Perrone S, Valle V, Natalino F, Barberi W, Scalzulli E, Torelli GF, Puzzolo MC, Foà R. Iori AP, et al. Among authors: scalzulli e. Leuk Lymphoma. 2013 Mar;54(3):669-70. doi: 10.3109/10428194.2012.715348. Epub 2012 Oct 4. Leuk Lymphoma. 2013. PMID: 23036078 No abstract available.

3

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life.

Breccia M, Colafigli G, Molica M, Scalzulli E, Diverio D, Latagliata R, Guarini A, Foà R. Breccia M, et al. Among authors: scalzulli e. Am J Hematol. 2017 Dec;92(12):E668-E670. doi: 10.1002/ajh.24916. Epub 2017 Oct 19. Am J Hematol. 2017. PMID: 28960424 Free article. No abstract available.

4

Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.

Molica M, Scalzulli E, Colafigli G, Fegatelli DA, Massaro F, Latagliata R, Foà R, Breccia M. Molica M, et al. Among authors: scalzulli e. Ann Hematol. 2018 Oct;97(10):1803-1808. doi: 10.1007/s00277-018-3375-9. Epub 2018 May 27. Ann Hematol. 2018. PMID: 29806063

5

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia.

Molica M, Scalzulli E, Colafigli G, Foà R, Breccia M. Molica M, et al. Among authors: scalzulli e. Ther Adv Hematol. 2019 Mar 1;10:2040620719826444. doi: 10.1177/2040620719826444. eCollection 2019. Ther Adv Hematol. 2019. PMID: 30854182 Free PMC article. Review.

6

Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome.

Colafigli G, Scalzulli E, Porrazzo M, Diverio D, Loglisci MG, Latagliata R, Guarini A, Foà R, Breccia M. Colafigli G, et al. Among authors: scalzulli e. Hematol Oncol. 2019 Dec;37(5):652-654. doi: 10.1002/hon.2650. Epub 2019 Aug 5. Hematol Oncol. 2019. PMID: 31321792 No abstract available.

7

Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients.

Scalzulli E, Colafigli G, Latagliata R, Pepe S, Diverio D, Stocchi F, Di Prima A, Efficace F, Martelli M, Foà R, Breccia M. Scalzulli E, et al. Ann Hematol. 2020 Dec;99(12):2773-2777. doi: 10.1007/s00277-020-04096-1. Epub 2020 May 28. Ann Hematol. 2020. PMID: 32462330

8

Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up.

Scalzulli E, Colafigli G, Pepe S, De Luca G, Di Prima A, Efficace F, Diverio D, Latagliata R, Martelli M, Foà R, Breccia M. Scalzulli E, et al. Leuk Lymphoma. 2021 Apr;62(4):1026-1027. doi: 10.1080/10428194.2020.1808205. Epub 2020 Aug 16. Leuk Lymphoma. 2021. PMID: 32799601 No abstract available.

9

Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience.

Pepe S, Scalzulli E, Colafigli G, Di Prima A, Diverio D, Mancini M, Latagliata R, Martelli M, Foà R, Breccia M. Pepe S, et al. Among authors: scalzulli e. Ann Hematol. 2020 Oct;99(10):2405-2416. doi: 10.1007/s00277-020-04217-w. Epub 2020 Aug 19. Ann Hematol. 2020. PMID: 32813071

10

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.

Di Prima A, Botticelli A, Scalzulli E, Colafigli G, Pepe S, Lisi C, Marchetti P, Martelli M, Foà R, Breccia M. Di Prima A, et al. Among authors: scalzulli e. Ann Hematol. 2021 Aug;100(8):2117-2119. doi: 10.1007/s00277-020-04236-7. Epub 2020 Aug 27. Ann Hematol. 2021. PMID: 32856142 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters